145 related articles for article (PubMed ID: 32272297)
21. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
[TBL] [Abstract][Full Text] [Related]
22. Low baseline salivary alpha-amylase in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubała WJ; Landowski J
J Affect Disord; 2014 Mar; 157():14-7. PubMed ID: 24581822
[TBL] [Abstract][Full Text] [Related]
23. Large-scale evidence for an association between low-grade peripheral inflammation and brain structural alterations in major depression in the BiDirect study.
Opel N; Cearns M; Clark S; Toben C; Grotegerd D; Heindel W; Kugel H; Teuber A; Minnerup H; Berger K; Dannlowski U; Baune BT
J Psychiatry Neurosci; 2019 Nov; 44(6):423-431. PubMed ID: 31304733
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk.
Wiener CD; de Mello Ferreira S; Pedrotti Moreira F; Bittencourt G; de Oliveira JF; Lopez Molina M; Jansen K; de Mattos Souza LD; Rizzato Lara D; Portela LV; da Silva RA; Oses JP
J Affect Disord; 2015 Sep; 184():245-8. PubMed ID: 26118751
[TBL] [Abstract][Full Text] [Related]
25. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls.
Matsuzaka H; Maeshima H; Kida S; Kurita H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
Int J Psychiatry Med; 2013; 46(2):203-21. PubMed ID: 24552043
[TBL] [Abstract][Full Text] [Related]
26. Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study.
Rahman S; Shanta AA; Daria S; Nahar Z; Shahriar M; Qusar MS; Islam SMA; Bhuiyan MA; Islam MR
PLoS One; 2022; 17(2):e0264404. PubMed ID: 35213631
[TBL] [Abstract][Full Text] [Related]
27. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
28. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
29. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
[TBL] [Abstract][Full Text] [Related]
30. Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids.
Rupprecht R; Rupprecht C; Di Benedetto B; Rammes G
World J Biol Psychiatry; 2022; 23(4):257-263. PubMed ID: 34320915
[TBL] [Abstract][Full Text] [Related]
31. Serum C1q Concentration Positively Correlates with Erythrocyte Sedimentation Rate in Polymyositis/Dermatomyositis.
Li L; Chen J; Chen S; Liu C; Zhang F; Li Y
Ann Clin Lab Sci; 2019 Mar; 49(2):237-241. PubMed ID: 31028070
[TBL] [Abstract][Full Text] [Related]
32. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
[TBL] [Abstract][Full Text] [Related]
33. Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels.
Akcan U; Karabulut S; İsmail Küçükali C; Çakır S; Tüzün E
Acta Neuropsychiatr; 2018 Apr; 30(2):70-78. PubMed ID: 28399943
[TBL] [Abstract][Full Text] [Related]
34. Decreased plasma glial cell line-derived neurotrophic factor level in major depressive disorder is associated with age and clinical severity.
Sun J; Kong L; Wu F; Wei Y; Zhu Y; Yin Z; Deng X; Jiang X; Tang Y; Wang F
J Affect Disord; 2019 Feb; 245():602-607. PubMed ID: 30445385
[TBL] [Abstract][Full Text] [Related]
35. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy.
Emon MPZ; Das R; Nishuty NL; Shalahuddin Qusar MMA; Bhuiyan MA; Islam MR
BMC Res Notes; 2020 Feb; 13(1):83. PubMed ID: 32085720
[TBL] [Abstract][Full Text] [Related]
36. The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls.
Karakula-Juchnowicz H; Gałęcka M; Rog J; Bartnicka A; Łukaszewicz Z; Krukow P; Morylowska-Topolska J; Skonieczna-Zydecka K; Krajka T; Jonak K; Juchnowicz D
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29710769
[TBL] [Abstract][Full Text] [Related]
37. Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: a comparative cross-sectional study.
Chen JX; Feng JH; Zhang LG; Liu Y; Yang FD; Wang SL; Tan YL; Su YA
BMC Psychiatry; 2020 Sep; 20(1):477. PubMed ID: 32993584
[TBL] [Abstract][Full Text] [Related]
38. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.
Michailidou I; Willems JG; Kooi EJ; van Eden C; Gold SM; Geurts JJ; Baas F; Huitinga I; Ramaglia V
Ann Neurol; 2015 Jun; 77(6):1007-26. PubMed ID: 25727254
[TBL] [Abstract][Full Text] [Related]
39. Low baseline salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubała WJ; Landowski J; Wielgomas B; Czarnowski W
J Affect Disord; 2014 Jun; 161():4-7. PubMed ID: 24751300
[TBL] [Abstract][Full Text] [Related]
40. Serum C1q as a novel biomarker of sarcopenia in older adults.
Watanabe S; Sato K; Hasegawa N; Kurihara T; Matsutani K; Sanada K; Hamaoka T; Fujita S; Iemitsu M
FASEB J; 2015 Mar; 29(3):1003-10. PubMed ID: 25491308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
